Slide 1: FY25 Results Presentation
FY25 Results Presentation 28 August 2025
Slide 2: Disclaimer
Disclaimer The information contained in this document (“Document”) has been prepared by Alcidion Group Limited ACN 143 142 any change in expectations in relation to any such statements or any change in events, conditions or circumstances 410 (referred to as “Alcidion” or “Company”). This Document is
Slide 3: Snapshot
01. Snapshot ALCIDION CORPORATE OVERVIEW
Slide 4: Alcidion: best-in-class – strong momentum and increasing scale
Alcidion: best-in-class – strong momentum and increasing scale Healthcare software and informatics company revolutionising efficiency and quality of care Industry leading, 100+ clinical Strong financial profile Highly experienced team Compelling platform Australian-made implementations in (FY25 reve
Slide 5: Strong Market Share
Strong Market Share 108 Health Services Global footprint across the UK, Australia & NZ. 10 Health Systems 447 Hospitals 100+ clinical system implementations. 11 Health Systems 28 Hospitals A platform approach to modernising healthcare assets and transforming the clinician experience. 5
Slide 6: What is Miya Precision?
What is Miya Miya Precision is a data platform for healthcare. However, it is more than that - Miya Precision digitises the clinical workflow and Precision? provides the foundation for the application of AI capability in healthcare. Designed for AI Miya Precision has been designed for AI, enabling 3
Slide 7: Smarter Solutions for Clinicians
Smarter Solutions for Clinicians Solutions Powering Smarter Care At the core of Alcidion’s solutions Patient Flow Emergency Modular EPR Virtual Care Integrated is our FHIR-based interoperability & Command Emergency Modular cloud- Virtual care and Care Record platform for smarter decision support Dig
Slide 8: The modular Miya Precision platform
The modular Miya Precision platform real time analytics icon resolve icon graph icon hospital icon eye icon Real Time Analytics Predictive Analytics Outlier Resolution Capacity Management Discharge Barriers highly extensible icon peak icon barrier icon Hospital at a Glance Patient Logistics Mgmt. Sy
Slide 9: FY25 Highlights
02. FY25 Highlights EXECUTIVE SUMMARY
Slide 10: A Record Year for Alcidion
A Record Year for Alcidion Building blocks in place to accelerate global growth 1 Scale - FY25 revenue of $40.8M with geographical split 63% from UK & 37% from ANZ 2 Validation - New TCV1 of $73.8M, up 109% pcp; led by milestone $39m+ EPR2 contract 3 Profitability - Record Underlying EBITDA3 of $5.1
Slide 11: FY25 – Financial Highlights
FY25 – Financial Highlights A record year across all key financial metrics $40.8M $28.5M $73.8M $5.1M $5.8M FY25 revenue ARR1 (as at 30 Jun-25) FY25 new & renewal TCV Underlying EBITDA3 Operating Cashflow positive Up 10% on pcp1 Up 31% on 30 Jun-24 Up 109% on pcp Up $8.5M Vs. ($3.4m) Up $12.9M vs. (
Slide 12: FY25 – Operational Highlights
FY25 – Operational Highlights A record year for new TCV wins; long-term contracts position for future success › New contracts: › Jul-24: Hume Rural Health Alliance (AUS): Miya Precision as an enterprise digital platform; focus on patient flow New & › Nov-24: North Adelaide Local Health Network (AUS)
Slide 13: Financial Results
03. Financial Results FY25 RESULTS
Slide 14: Profit & Loss
Profit & Loss Record Revenue and Underlying EBITDA; underpinned by growth in ARR Profit & loss (A$000) FY24 FY25 % Change 1 › Annual recurring product revenue (M&S + Annual Licenses) in FY25 reflects Recurring only partial contribution from new customers won during FY25 Product - M&S + Annual licenc
Slide 15: Revenue Dashboard
Revenue Dashboard 40.4 40.8 37.1 H1 vs H2 34.4 21.4 23.1 Geographical Revenue 21.5 18.0 Split (%) 25.9 37% Split ($M) 14.8 $40.8M 19.0 19.1 Total 17.6 UK ANZ 63% 12.9 11.1 FY21 FY22 FY23 FY24 FY25 H1 H2 40.8 40.4 37.1 Revenue 34.4 4.8 % Recurring 57% 41% 39% 29% 36% 10.0 1.6 Category 25.9 6.2 7.5 8.
Slide 16: Our revenue model & breakdown
Our revenue model & breakdown… Licence fees + Maintenance & Support (M&S) recurring revenue will underpin future sustainable and increasingly profitable growth Products >95%1 Technical Services <5%1 Core Offering Key Product / Data analytics, Integration, Services interoperability & technical design
Slide 17: Balance Sheet
Balance Sheet Significant balance sheet flexibility to pursue growth opportunities Balance sheet ($000) FY24 FY25 Cash & cash equivalents 1 11,798 17,697 1 › $17.7m cash and no debt as of 30 June 2025 Trade & other receivables 5,214 3,680 Other assets 1,527 2,310 Current assets 18,539 23,688 2 › Rel
Slide 18: Cashflow
Cashflow Cash flow ($000) FY24 FY25 › Cash receipts materially exceeding revenue largely driven by inclusion Receipts from customers 1 43,881 50,858 1 Payments to suppliers & employees (50,831) (45,162) of relevant jurisdiction tax (ie. 10% GST in Australian and 20% VAT in UK) Interest received 83 1
Slide 19: Operational Success
04. Operational Success POSITIONED FOR GROWTH
Slide 20: Notable New Contract Wins
Notable New Contract Wins New contracts reinforce modular strategy, catering to needs of customers as they enhance their digital maturity Hume Rural Health Alliance (AUS) Hywel Dda (Wales) › Miya Precision deployed as an enterprise › Miya Precision – Patient Flow, Observations digital platform acros
Slide 21: EPR Validation: North Cumbria
EPR Validation: North Cumbria Signed contract with North Cumbria Integrated Care NHS Foundation Trust (NCIC) for new EPR platform solution Key Contract Terms Contract Signed - Overview › Selected following a competitive tender process › Deploy Miya Precision encompassing full suite offering incl. Si
Slide 22: Notable Extension / Expansion Wins
Notable Extension / Expansion Wins Continuing to build on deeply embedded and long-standing relationships NT Health (AUS) Several PCS customers (UK) › Builds upon existing 9+ year relationship PCS › Extended several PCS customers (product name › Miya Precision to include reseller arrangement Custome
Slide 23: Successful Deployments in FY25
Successful Deployments in FY25 Product Implementation and technical service delivery have always been a strength of the Alcidion business Hume Rural Health Alliance (AUS) Hampshire Hospitals NHS Foundation Trust › First site went ‘live’ in late Oct-24 › First deployment of Miya Emergency across › Ad
Slide 24: Modular / Expansion sales driving TCV uplift
Modular / Expansion sales driving TCV uplift Delivering tangible examples of strategies success… Hume (Aust.) North Cumbria (UK) South Tees (UK) NT Health • Q1’25 – New contract covering 15 • Q3’25 – Milestone 10-year • Q2’20 - 5 years for several Miya • Extended to include Smartpage hospitals acros
Slide 25: Outlook
06. Outlook STRONG OUTLOOK AND GROWTH POTENTIAL
Slide 26: Outlook
Outlook Momentum continuing into FY26 underpinned by high contracted revenue coupled with maturing pipeline of expansion & new opportunities As of 30 June 2025, contracted & Targeting to be FY26 EBITDA positive Started market testing, partner renewal revenue to be recognised in and deliver positive
Slide 27: Investment Highlights
Investment Highlights Large Addressable Market Strong Financial Profile Strong Marquee Customers › Strong foothold within approximately 1/3rd of › $40.8M FY25 revenue › $39.0M+ over 10 years with North Cumbria UK NHS acute Trusts using at least one ALC for Miya Precision suite to provide new EPR › $
Slide 28: @ ALCIDION
A @ ALCIDION